Stakeholders’ consensus response to the proposed European Health Data Space
29 Nov 2022
On 29 November, EORTC joined a group of 35 stakeholders in welcoming the European Commission’s proposal on the European Health Data Space. The stakeholders, which include medical professional and research organisations, patient representatives, industry associations and data collaborations strongly support the aims of the EHDS as proposed by the European Commission. We believe the adoption of the new legislation “can bring important European alignment to, and rapidly scale up, well-governed access to health data sets for the delivery of healthcare services but also for a wide range of secondary use purposes for better health outcomes.”
The consensus statement encourages decision-makers to strongly support this Regulation and to engage with stakeholders to ensure the final Regulation optimises its potential. The statement also formulates several recommendations to consider when developing the more specific implementation plans to put this
Regulation into practice across the Member States:
1. A broad range of stakeholders must be strongly involved from the outset of the process to guarantee the success of the EHDS.
2. The EHDS must align with all relevant horizontal and sectoral European laws.
3. There must be harmonised interpretation and implementation of the Regulation across the EU.
4. Approvals for secondary use of health data must be consistent and harmonised across Europe.
5. The scope of EHR systems must be defined clearly within the Regulation.
6. The successful implementation of the EHDS must be adequately resourced.
7. Existing health data infrastructures must be leveraged to allow continuity and build on existing expertise.
Read the full statement here.
Related News
EORTC Quality of Life Group unveils flexible, future-focused strategy for patient-reported outcome assessment in cancer care
22 Apr 2025
EMA-EORTC workshop underscores critical role of patient-reported outcomes and quality of life data in regulatory decision-making
15 Apr 2025
New study confirms link between cancer patients’ quality of life and survival
1 Apr 2025
New Treatment for Recurrent Meningioma: LUMEN-1 Clinical Trial
17 Mar 2025
SISAQOL-IMI Consortium Launches Final Recommendations
6 Feb 2025
World Cancer Day 2025: EORTC’s commitment to older patients
4 Feb 2025
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024
IMMUcan has completed patient enrolment
12 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
5 Nov 2024